The Marcus Center for Cellular Cures (MC3) is a collaboration between Duke’s Pratt School of Engineering and Duke University School of Medicine. The Center seeks to develop transformative clinical therapies using cells, tissues, molecules, genes, and biomaterials to treat diseases and injuries that currently lack effective treatments. Example of these diseases include autism and related neurodevelopmental disorders, cerebral palsy, stroke, multiple sclerosis, and other related brain disorders.